References
- Bickel M. H. The pharmacology and biochemistry of N‐oxides. Pharmacological Reviews 1969; 21: 325–355
- Bliss E. A., Griffin R. J., Stevens M. F. G. Structural studies on bioactive compounds. Part 5. Synthesis and properties of 2,4‐diaminopyrimidine dihydrofolate reductase inhibitors bearing lipophilic azido groups. Journal of the Chemical Society Perkin Transactions I 1987; 2217–2227
- Brown J. R. Structural origins of mammalian albumin. Federation Proceedings 1976; 35: 2141
- Cartwright I. L., Hutchinson D. W., Armstrong V. W. The reaction between thiols and 8‐azidoadenosine derivatives. Nucleic Acids Research 1976; 3: 2331–2339
- Chaykin S. Biochemistry Laboratory Techniques. John Wiley & Sons, Inc., New York 1966; 116
- Ehia G. B., Callahan S., Hathan H., Bieber S., Rundless R. W., Hitchings G. H. Potentiation by inhibition of drug degradation: 6‐substituted purines and xanthine oxidase. Biochemical Pharmacology 1963; 12: 85–93
- Gibson G. G., Skett P. Introduction to Drug Metabolism. Chapman & Hall, London 1986; 242
- Slack J. A., Pashley S. G. H., Stevens M. F. G., Griffin R. J. Analysis and preclinical pharmacology of the new lipophilic DHFR inhibitor MZPES. Proceedings of the American Association for Cancer Research 1986; 27: 403
- Slack J. A., Blackledge G. R. P., Newlands E. S., Stuart N., Crawford S. M., Wong S. K., Pashley S. G. H., Brindley C. J., Hoffman R., Stevens M. F. G. Clinical pharmacokinetics of m‐azidopyrimethamine (MZP). Proceedings of the American Association for Cancer Research 1987; 28: 188
- Staros J. V., Bayley H., Standring D. H., Knowles J. R. Reduction of aryl azides by thiols: Implications for the use of photoaffinity reagents. Biochemical and Biophysical Research Communications 1978; 80: 568–572
- Stevens M. F. G., Griffin R. J., Wong S. K. The aromatic azido group in anti‐cancer drug design: application in the development of novel lipophilic dyhydrofolate reductase inhibitors. Anti‐Cancer Drug Design 1987; 2: 311–318
- Stuart N. S. A., Crawford S. M., Blackledge G. R. P., Newlands E. S., Slack J. A., Stevens M. F. G. A phase 1 study of meta‐azidopyrimethamine ethane sulphonate (MZPES)—a new dihydrofolate reductase inhibitor
- Wolpert M. K., Althaus J. R., Johns D. G. Nitroreductase activity of mammalian liver aldehyde oxidase. Journal of Pharmacology and Experimental Therapeutics 1973; 185: 202–213